Profile data is unavailable for this security.
About the company
Cambridge Cognition Holdings plc is a United Kingdom-based company, which is engaged in developing and marketing digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB, Electronic Clinical Outcomes Assessment (eCOA), NeuroVocalix, Winterlight, Cognition Kit, Clinpal, eConsent, and AQUA. CANTAB Connect gives the control to manage and deliver battery of touchscreen and voice assessments, as well as fully customizable electronic questionnaires and scales. The Company’s therapeutic areas include attention deficit hyperactivity disorder (ADHD), Alzheimer’s Disease, Autism Spectrum Disorder, Cognitive Safety, Core Cognitive Function, Depression, Down’s Syndrome, Drug Abuse Liability, Epilepsy, Huntington’s Disease, Multiple Sclerosis, Neuromuscular Disorders, Obsessive Compulsive Disorder, Parkinson’s Disease, Schizophrenia, Stroke and Cerebrovascular Disease, and Traumatic Brain Injury.
- Revenue in GBP (TTM)13.52m
- Net income in GBP-3.51m
- Incorporated2012
- Employees119.00
- LocationCambridge Cognition Holdings PLCTunbridge CourtTunbridge Lane, BottishamCAMBRIDGE CB25 9TUUnited KingdomGBR
- Websitehttps://www.cambridgecognition.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
ITIM Group Plc | 16.13m | -892.00k |
Induction Healthcare Group PLC | 11.82m | -14.18m |
Arcontech Group PLC | 2.82m | 1.15m |
4Global PLC | 5.94m | 767.49k |
GSTechnologies Ltd | -907.58k | -644.09k |
Cambridge Cognition Holdings PLC | 13.52m | -3.51m |
Pebble Beach Systems Group PLC | 12.37m | 1.53m |
Ingenta PLC | 10.83m | 2.30m |
Blackbird PLC | 1.94m | -2.49m |
Crimson Tide plc | 6.16m | -305.00k |
Renalytix PLC | 2.69m | -36.57m |
Finseta PLC | 9.65m | 2.13m |
Narf Industries PLC | 3.27m | -14.57m |
Insig Ai PLC | 2.02m | -17.56m |
essensys PLC | 24.08m | -10.73m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Canaccord Genuity Wealth Ltd.as of 18 Jun 2024 | 3.80m | 10.81% |
Octopus Investments Ltd.as of 18 Jun 2024 | 3.79m | 10.77% |
Lombard Odier Asset Management (USA) Corp.as of 11 Jan 2023 | 2.85m | 8.11% |
J.O. Hambro Capital Management Ltd.as of 27 Jan 2023 | 1.75m | 4.98% |
AXA Investment Managers UK Ltd.as of 11 Jan 2023 | 1.05m | 2.99% |